No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
531 |
4. Check minimum number of eventsNone |
531 |
5. Include endpointsNone |
531 |
6. Filter based on genotype QC (FinnGen only) |
531 |
Control definitions (FinnGen only)
- Control exclude
- I9_DISVEINLYMPH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I80-I89
- Name in latin
- Thrombosis venae portae
Similar endpoints
↥List of similar endpoints to
Portal vein thrombosis
based on the number of shared cases.
Similar with more cases:
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified
- Cardiovascular diseases (excluding rheumatic etc)
- Cardiovascular diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3823 | 1578 | 2210 |
| Only index persons | 3061 | 1272 | 1789 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | 0.06 |
| Only index persons | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 62.20 | 62.36 | 62.10 |
| Only index persons | 61.19 | 60.50 | 61.68 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 531 | 226 | 305 |
| Unadjusted period prevalence (%) | 0.11 | 0.08 | 0.13 |
| Median age at first event (years) | 61.88 | 60.07 | 63.22 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 459
- Matched controls
- 4588
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I81
ICD-10 Finland
Portal vein thrombosis
+∞
323.0
440
*
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
+∞
96.3
89
*
B01AB05
ATC
enoxaparin; parenteral
7.3
83.6
282
818
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
5.7
64.2
261
862
JN3BD
NOMESCO Finland
Extensive abdominal CT
8.1
59.6
151
262
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.3
58.7
163
323
B01AA03
ATC
warfarin; systemic
5.6
54.3
199
554
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
8.9
52.9
123
182
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
470.1
44.0
43
*
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
+∞
38.0
36
*
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
141.7
37.3
39
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
42.4
37.3
46
12
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
22.5
37.1
54
27
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
25.4
35.7
50
22
B01AB10
ATC
tinzaparin; parenteral
7.9
34.3
83
125
R18
ICD-10 Finland
Ascites
18.8
33.7
52
31
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.5
32.7
219
959
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
334.6
31.2
31
*
JN3AD
NOMESCO Finland
Abdominal CT examination
6.0
30.5
90
178
C03DA01
ATC
spironolactone; oral
4.9
29.0
104
257
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.3
29.0
73
116
Z51.5
ICD-10 Finland
Palliative care
6.9
26.2
68
112
C03CA01
ATC
furosemide; systemic
3.1
26.2
195
884
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
26.0
263
1453
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.5
25.5
100
268
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
5.3
24.9
81
178
K92.1
ICD-10 Finland
Melaena
6.4
24.8
68
121
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
91.7
23.9
26
*
PHD99
NOMESCO Finland
Resection of other vein
252.6
23.9
24
*
N02AA05
ATC
oxycodone; systemic
3.8
23.6
112
356
JN4BD
NOMESCO Finland
Extensive body CT
4.4
23.5
94
256
TPH04
NOMESCO Finland
Cathetrisation of vein
3.2
23.3
150
603
45499
ICD-8 Finland
Varicose veins of lower extremities, Other and unspecified, without ulcer
+∞
23.1
22
*
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
20.3
22.9
34
18
130
Kela drug reimbursment
Malignant tumour
4.8
22.9
82
199
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
13.2
22.3
39
32
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.5
22.0
118
413
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
40.9
22.0
27
7
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
18.6
21.7
33
19
K83.0
ICD-10 Finland
Cholangitis
20.1
21.6
32
17
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
7.1
21.1
53
83
JAH00
NOMESCO Finland
Laparotomy
9.2
20.9
44
52
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
8.5
20.8
46
59
N02AX02
ATC
tramadol; systemic, rectal
2.6
20.8
236
1330
A06AD11
ATC
lactulose; oral
3.4
20.8
113
398
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
27.0
20.7
28
11
B01AB04
ATC
dalteparin; parenteral
6.5
20.3
54
92
R50.9
ICD-10 Finland
Fever, unspecified
3.5
20.1
104
351
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
11.7
20.1
37
34
A03FA01
ATC
metoclopramide; systemic, rectal
3.1
19.7
127
504
UJF32
NOMESCO Finland
Coloscopy
2.8
19.6
157
715
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
13.1
18.9
33
27
A02BC02
ATC
pantoprazole; systemic
2.5
18.7
323
2230
K86.1
ICD-10 Finland
Other chronic pancreatitis
31.5
18.5
24
8
C07AA05
ATC
propranolol; systemic
3.1
18.5
117
456
A09AA02
ATC
multienzymes (lipase, protease etc.)
14.5
18.0
30
22
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.2
17.8
106
394
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.8
17.7
51
96
Z94.4
ICD-10 Finland
Liver transplant status
186.9
17.6
18
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
12.7
17.6
31
26
K92.0
ICD-10 Finland
Haematemesis
9.4
17.5
36
41
XF400
NOMESCO Finland
ECG with 12 standard connections
3.0
17.5
116
465
J01MA12
ATC
levofloxacin; systemic
2.9
17.3
121
502
ZXD05
NOMESCO Finland
Urgent procedure
2.5
17.3
175
900
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
14.8
17.0
28
20
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
18.8
16.6
25
14
K94
ICPC
Phlebitis/thrombophlebitis
41.7
16.5
20
5
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
31.3
16.2
21
7
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.1
15.9
39
59
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
10.3
15.9
31
32
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
18.0
15.8
24
14
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
18.0
15.8
24
14
45299
ICD-8 Finland
Portal vein thrombosis
+∞
15.7
15
*
D45
ICD-10 Finland
Polycythaemia vera
20.1
15.7
23
12
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
8.6
15.3
33
41
A05AA02
ATC
ursodeoxycholic acid; oral
18.6
15.3
23
13
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
46.7
15.2
18
*
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
26.0
14.8
20
8
K83.1
ICD-10 Finland
Obstruction of bile duct
12.5
14.8
26
22
WX002
NOMESCO Finland
Sedation and analgesia
2.7
14.6
116
512
JJC00
NOMESCO Finland
Allogenic transplantation of liver
154.7
14.5
15
*
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
154.7
14.5
15
*
UJK02
NOMESCO Finland
ERCP
9.6
14.4
29
32
J01MA02
ATC
ciprofloxacin; systemic
2.2
14.2
208
1251
C07AG02
ATC
carvedilol; oral
4.6
14.2
50
118
UJF30
NOMESCO Finland
Ileoscopy through colon
3.5
14.2
69
219
WW500
NOMESCO Finland
Blood transfusion
5.9
14.0
39
71
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
8.4
13.8
30
38
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
13.7
153
810
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
13.6
77
273
JN4AD
NOMESCO Finland
Body CT examination
3.9
13.6
58
165
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
18.9
13.5
20
11
ZX120
NOMESCO Finland
Intravenous
3.4
13.4
68
223
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
13.2
98
414
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.5
13.1
34
56
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.9
12.9
29
39
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
14.6
12.9
21
15
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.7
12.8
57
168
D64.9
ICD-10 Finland
Anaemia, unspecified
3.3
12.8
68
231
A10AE04
ATC
insulin glargine; parenteral
3.3
12.7
66
220
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
6.1
12.7
34
59
A04AA02
ATC
granisetron; systemic, transdermal
4.5
12.6
45
108
4549X
ICD-9 Finland
Varicose veins of lower extremities, Without mention of ulcer or inflammation
+∞
12.6
12
*
JCA32
NOMESCO Finland
Endoscopic injection in oesophagus
+∞
12.6
12
*
D68.8
ICD-10 Finland
Other specified coagulation defects
20.7
12.5
18
9
R4110
NOMESCO Finland
Physiotherapy
2.3
12.5
142
749
PHD76
NOMESCO Finland
Resection of long saphenous vein
133.5
12.5
13
*
K76.6
ICD-10 Finland
Portal hypertension
133.5
12.5
13
*
127
Kela drug reimbursment
Transplant complication
12.1
12.4
22
19
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
12.1
12.4
22
19
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
10.9
12.4
23
22
L01BC06
ATC
capecitabine; oral
5.9
12.3
34
61
UJD02
NOMESCO Finland
Gastroscopy
4.4
12.2
44
107
K76.9
ICD-10 Finland
Liver disease, unspecified
9.7
12.1
24
26
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.9
12.0
39
85
K86.3
ICD-10 Finland
Pseudocyst of pancreas
48.0
11.9
14
*
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
6.1
11.9
32
56
K72.1
ICD-10 Finland
Chronic hepatic failure
+∞
11.5
11
*
I86.4
ICD-10 Finland
Gastric varices
+∞
11.5
11
*
4520A
ICD-9 Finland
Portal vein thrombosis[THROMBOSIS VENAE PORTAE]
+∞
11.5
11
*
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
4.6
11.4
39
90
K85
ICD-10 Finland
Acute pancreatitis
10.0
11.4
22
23
Z2221
NOMESCO Finland
Medical doctor
2.2
11.4
142
780
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.1
11.3
44
115
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
11.3
59
198
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
20.7
11.2
16
8
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
6.0
11.1
30
53
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
14.4
11.1
18
13
H02AB02
ATC
dexamethasone; systemic
3.1
10.9
61
213
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
8.6
10.9
23
28
A02BC05
ATC
esomeprazole; systemic
2.0
10.8
194
1232
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
22.1
10.7
15
7
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
22.1
10.7
15
7
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
10.6
84
368
JCA20
NOMESCO Finland
Ligature of oesophageal varices
+∞
10.5
10
*
L01XX05
ATC
hydroxycarbamide; oral
12.4
10.4
18
15
JN4CD
NOMESCO Finland
Very extensive body CT
4.3
10.4
38
94
Z3231
NOMESCO Finland
Registered nurse
2.1
10.3
143
815
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
8.7
10.2
21
25
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.3
10.1
37
92
ZXE00
NOMESCO Finland
One hour or less
2.0
10.0
186
1188
P01AB01
ATC
metronidazole; oral, rectal
2.0
10.0
177
1109
WX892
NOMESCO Finland
Monitored bed care
3.1
9.9
55
191
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
11.0
9.9
18
17
R4190
NOMESCO Finland
Nutritional therapy
5.6
9.8
28
53
WZC30
NOMESCO Finland
Teaching
2.7
9.8
71
295
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.3
9.7
49
160
K85.1
ICD-10 Finland
Biliary acute pancreatitis
56.2
9.7
11
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
9.7
84
385
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
9.7
49
161
Z3226
NOMESCO Finland
Physiotherapist
2.3
9.6
97
478
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
11.7
9.6
17
15
A41.9
ICD-10 Finland
Sepsis, unspecified
4.7
9.5
31
69
A02BC01
ATC
omeprazole; systemic
2.0
9.5
139
806
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
102.1
9.4
10
*
PHM76
NOMESCO Finland
Endovenous obliteration of v.saphena magna
102.1
9.4
10
*
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
30.7
9.4
12
*
TPH00
NOMESCO Finland
Phlebotomy
30.7
9.4
12
*
WX882
NOMESCO Finland
High dependency care
5.5
9.4
27
52
TK800
NOMESCO Finland
Hemodialysis
9.0
9.4
19
22
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
11.0
9.4
17
16
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
14.0
9.2
15
11
L04AA06
ATC
mycophenolic acid; systemic
8.6
9.2
19
23
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
9.0
123
691
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.0
8.9
129
741
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.6
8.9
68
288
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
12.9
8.9
15
12
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.9
8.9
18
21
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.8
8.9
24
43
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
8.8
150
919
A07AA11
ATC
rifaximin; oral
51.0
8.7
10
*
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
6.2
8.6
22
37
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
28.1
8.5
11
*
J81
ICD-10 Finland
Pulmonary oedema
28.1
8.5
11
*
5611
FHL
Vena saphena Magna and / or swarm of nodule and possible local emissions
91.7
8.4
9
*
K76.89
ICD-10 Finland
Other specified diseases of liver
91.7
8.4
9
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
13.1
8.4
14
11
4511A
ICD-9 Finland
Phlebitis and thrombophlebitis, Of deep vessels of lower extremities
+∞
8.4
8
*
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.6
8.3
60
248
XW000
NOMESCO Finland
Bone marrow biopsy
3.9
8.3
33
89
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.2
8.2
30
75
A04AA01
ATC
ondansetron; systemic, rectal
3.3
8.2
40
128
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.1
8.2
46
161
R60.0
ICD-10 Finland
Localized oedema
2.8
8.2
54
210
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
8.1
59
245
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.4
8.1
23
44
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
34.0
8.1
10
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
34.0
8.1
10
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
4.4
8.0
28
67
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
8.0
179
1197
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
8.0
100
538
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.7
8.0
26
58
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
7.9
167
1092
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
7.8
87
445
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.3
7.8
28
69
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.1
7.8
29
74
UJF92
NOMESCO Finland
Capsular endoscopy
6.6
7.8
19
30
JMA10
NOMESCO Finland
Transabdominal total splenectomy
15.4
7.8
12
8
JFB00
NOMESCO Finland
Partial resection of small intestine
7.6
7.7
17
23
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
7.6
7.7
17
23
K65.0
ICD-10 Finland
Acute peritonitis
12.1
7.6
13
11
K29.6
ICD-10 Finland
Other gastritis
10.3
7.6
14
14
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
7.6
91
481
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
5.2
7.5
22
44
RD210
NOMESCO Finland
NA
7.9
7.4
16
21
L03AB05
ATC
interferon alfa-2b; parenteral
81.4
7.4
8
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.8
7.4
47
180
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
8.6
7.4
15
18
A46
ICD-10 Finland
Erysipelas
2.3
7.3
73
354
J01DB01
ATC
cefalexin; oral
1.8
7.3
353
2963
K81.0
ICD-10 Finland
Acute cholecystitis
5.0
7.2
22
46
D01
ICPC
Abdominal pain/cramps general
2.7
7.2
47
184
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
20.4
7.2
10
5
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
12.3
7.1
12
10
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.0
7.1
40
142
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.7
7.0
29
82
Z2446
NOMESCO Finland
Social worker
2.9
7.0
40
144
JAH01
NOMESCO Finland
Laparoscopy
4.0
6.9
26
68
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
9.5
6.8
13
14
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
40.7
6.8
8
*
K99
ICPC
Cardiovascular disease other
5.1
6.7
20
41
SPAT1262
SPAT
Handing over of treatment supplies
2.0
6.6
92
515
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.8
6.6
26
71
N02BE01
ATC
paracetamol; systemic, rectal
1.8
6.6
372
3211
A41.8
ICD-10 Finland
Other specified sepsis
7.0
6.6
15
22
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
6.5
139
904
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.6
6.5
46
190
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
7.6
6.5
14
19
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.3
6.4
30
94
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.3
6.4
31
100
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
11.2
6.3
11
10
K56.7
ICD-10 Finland
Ileus, unspecified
11.2
6.3
11
10
K29.3
ICD-10 Finland
Chronic superficial gastritis
4.0
6.3
23
59
1324
FHL
Esophagoscopy and sclerotherapy
+∞
6.3
6
*
XX4BW
NOMESCO Finland
NA
+∞
6.3
6
*
JJ5AT
NOMESCO Finland
NA
+∞
6.3
6
*
I82.21
ICD-10 Finland
Emboli and thrombosis in the inferior vena cava
+∞
6.3
6
*
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
27.1
6.2
8
*
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
27.1
6.2
8
*
AA1AD
NOMESCO Finland
CT of head and brain
1.8
6.2
110
672
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
6.1
136
890
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.2
6.1
30
98
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.3
6.0
53
242
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
135
113
15.68
140.18
5.4
3.4
%
89.0
88.8
0.02
127
107
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
135
128
13.80
129.43
4.9
2.5
u/ml
0.3
0.4
0.72
86
66
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
216
381
8.87
128.91
4.9
2.1
g/l
0.2
0.2
9.22
202
355
(3036489) Thrombin time
129
129
12.89
119.03
5.2
3.0
s
24.6
21.5
1.38
108
118
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
85
44
22.81
111.75
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
79
45
20.45
99.27
1.3
1.4
u/ml
2.4
6.4
0.51
40
19
(4306422)
77
42
21.27
98.66
1.2
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
82
54
17.78
95.96
1.0
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
97
90
12.96
93.15
5.9
2.6
umol/l
45.4
32.6
3.31
86
72
(3007566) Smooth muscle Ab [Titer] in Serum
101
105
11.64
89.81
1.3
1.1
titre
81.8
111.7
—
11
6
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
102
112
11.03
87.19
6.6
3.6
g/l
3.5
3.7
0.27
97
107
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
195
475
5.91
80.44
9.3
2.6
umol/l
14.8
8.0
2.41
183
427
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
70
49
16.30
78.99
1.2
1.3
u/ml
3.2
5.5
0.55
32
21
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
113
181
7.66
70.59
3.4
3.2
u/ml
548.8
1232.5
0.38
102
156
(3032080) INR in Blood by Coagulation assay
379
1775
4.97
65.83
19.6
8.4
inr
1.5
1.2
4.00
105
495
(3033658) Prothrombin time (PT) actual/Normal
275
1028
4.47
64.53
13.8
3.9
%
75.1
90.0
13.67
268
1008
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
173
456
5.14
63.58
5.0
4.3
ug/l
4.7
40.4
1.29
145
387
(3024561) Albumin [Mass/volume] in Serum or Plasma
373
1819
4.53
58.89
12.9
4.7
g/l
32.4
35.7
18.13
357
1697
(3018677) aPTT in Platelet poor plasma by Coagulation assay
205
660
4.43
57.79
7.5
2.4
s
32.2
29.5
5.32
200
643
(3023368) Bacteria identified in Blood by Culture
283
1166
4.06
56.12
8.5
4.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
179
550
4.40
53.16
4.1
2.5
%
21.9
22.4
0.14
166
472
(3012095) Magnesium [Moles/volume] in Serum or Plasma
204
696
4.14
52.39
8.7
3.8
mmol/l
0.8
0.8
6.87
198
655
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
401
2200
4.36
50.29
21.3
6.3
umol/l
18.0
11.8
4.88
395
2094
(4268621)
49
40
13.39
50.23
2.3
2.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
181
583
4.19
50.07
3.9
2.5
g/l
2.2
2.3
0.99
170
540
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
140
380
4.65
48.45
6.4
2.3
u/l
490.8
45.2
0.48
131
321
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
36
18
21.38
47.22
6.1
3.2
%
93.2
107.4
0.97
36
18
(3005719) IgG [Mass/volume] in Serum or Plasma
124
317
4.80
46.09
2.0
2.8
g/l
11.4
10.3
1.53
119
287
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
287
1316
3.57
46.03
6.3
2.3
u/l
53.0
57.4
0.68
276
1212
(3022948) Iron [Moles/volume] in Serum or Plasma
180
631
3.80
43.33
4.1
2.5
umol/l
11.5
12.9
1.70
173
586
(3000570) Elastase.pancreatic [Mass/mass] in Stool
69
108
7.19
43.29
1.5
1.5
ug/g
203.5
303.7
3.42
50
71
(40768441) Liver Pathology biopsy report
42
35
12.94
42.40
1.9
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
157
521
3.86
40.68
34.1
21.3
inr
1.4
1.3
0.45
20
62
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
147
467
3.97
40.55
5.4
4.5
u/l
283.3
258.6
0.42
142
440
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
28
11
26.82
40.15
3.7
2.3
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
31
16
20.51
39.99
1.5
1.6
e6/l
1228.9
6253.9
—
15
10
(3020779) Urea [Moles/volume] in Serum or Plasma
125
357
4.27
39.90
10.8
8.8
mmol/l
8.4
10.0
1.67
120
340
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
109
285
4.55
39.00
2.0
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
279
1363
3.21
38.39
9.7
3.3
u/l
45.2
33.5
3.18
272
1302
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
30
16
19.81
38.12
1.3
1.2
ratio
1.1
1.1
—
11
7
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
39
35
11.95
37.52
1.5
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
163
587
3.56
36.97
2.9
2.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
28
14
21.06
36.55
2.0
2.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
150
535
3.51
34.25
8.9
6.6
mmol/l
1.0
1.0
0.60
141
501
(42870588) Differential panel, method unspecified - Blood
274
1390
3.01
34.18
10.2
6.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
258
1275
2.99
33.62
6.3
2.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
122
389
3.77
32.92
1.6
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
382
2379
3.16
31.91
18.3
9.4
e9/l
4.9
4.1
1.09
340
2065
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
126
420
3.62
31.73
1.5
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
25
14
18.69
30.95
1.2
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
25
14
18.69
30.95
1.9
1.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
324
1871
2.88
30.63
10.9
6.0
%
0.7
0.7
0.45
308
1752
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
344
2056
2.91
30.35
12.9
7.2
mmol/l
1.2
1.2
2.05
295
1748
(3037522) Nuclear Ab [Titer] in Serum
141
520
3.33
30.14
1.4
1.3
titre
457.9
441.2
0.03
29
103
(3006504) Eosinophils/100 leukocytes in Blood
328
1918
2.86
30.07
11.0
6.1
%
2.7
2.9
1.09
313
1793
(3019069) Monocytes/100 leukocytes in Blood
329
1930
2.85
29.92
11.6
6.4
%
9.4
8.9
1.76
314
1813
(3002030) Lymphocytes/100 leukocytes in Blood
334
1979
2.85
29.72
11.1
6.2
%
23.9
27.9
8.67
316
1848
(3026692) Albumin [Mass/volume] in Peritoneal fluid
23
12
19.99
29.34
1.3
1.0
g/l
9.5
18.0
—
15
7
(3018010) Neutrophils/100 leukocytes in Blood
329
1944
2.82
29.26
10.5
6.0
%
60.1
56.9
4.82
315
1826
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
188
833
2.95
29.11
4.6
1.8
mg/l
2.6
1.2
4.85
157
654
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
54
103
5.72
27.61
2.1
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
334
2038
2.72
27.05
10.3
5.9
e9/l
0.6
0.6
0.15
289
1732
(3006315) Basophils [#/volume] in Blood
334
2040
2.72
26.96
10.4
5.9
e9/l
0.0
0.0
0.35
289
1745
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
317
1898
2.66
26.47
11.6
6.4
mmol/l
1.2
1.2
3.07
304
1724
(3019198) Lymphocytes [#/volume] in Blood
337
2083
2.69
26.29
10.4
6.0
e9/l
1.6
1.9
6.27
296
1809
(3018418) pH of Serum or Plasma
235
1221
2.66
26.21
6.0
4.0
ph
7.4
7.4
0.00
52
230
(3013115) Eosinophils [#/volume] in Blood
339
2106
2.69
26.10
10.9
6.2
e9/l
0.2
0.2
1.57
294
1828
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
201
976
2.70
25.57
6.2
2.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
313
1906
2.56
24.55
8.1
3.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
46
85
5.83
24.27
9.0
7.1
iu/ml
155.8
173.3
—
9
16
(4281824)
31
37
8.84
24.24
1.3
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
128
506
3.02
23.80
3.9
2.7
%
2.0
1.8
0.90
106
460
(3026782) Osmolality of Urine
176
824
2.70
23.80
3.8
2.8
mosm/kgh2o
577.9
572.9
0.09
157
698
(3030467) Casts [#/volume] in Urine by Automated count
225
1190
2.55
23.63
4.0
3.2
e6/l
0.6
0.4
0.81
184
880
(3002582) Erythrocytes [#/volume] in Urine
241
1320
2.51
23.44
4.2
3.2
e6/l
45.8
110.7
0.63
200
1004
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
197
987
2.58
23.08
4.0
2.0
mg/l
4.1
3.0
3.92
176
842
(40768797) Stomach Pathology biopsy report
137
572
2.88
23.00
1.5
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
370
2486
2.61
22.83
10.3
4.9
mmol/l
7.3
6.7
4.75
362
2336
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
51
110
5.02
22.69
1.3
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
267
1561
2.43
22.15
4.3
3.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
64
169
4.17
22.13
2.8
2.0
ug/l
4.8
3.0
0.29
57
154
(3002032) Base excess in Venous blood by calculation
107
397
3.12
22.10
6.3
4.5
mmol/l
1.9
1.8
0.05
84
323
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
21
16
13.62
22.08
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
21
16
13.62
22.08
1.0
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
215
1148
2.47
21.73
4.0
3.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
107
401
3.09
21.70
6.2
4.4
kpa
5.6
5.7
0.40
101
392
(3000991) Gas panel - Venous blood
102
375
3.13
21.36
10.9
10.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
437
3255
2.94
20.76
23.9
7.5
u/l
122.5
79.2
13.40
428
3045
(3000850) Epithelial cells [#/volume] in Urine
176
874
2.52
20.63
3.3
2.5
e6/l
5.7
4.4
0.82
163
770
(3006922) Hepatitis E virus Ab [Presence] in Serum
21
18
12.11
20.58
1.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
99
385
2.93
18.64
4.4
2.8
e9/l
80.0
71.4
1.05
73
303
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
62
183
3.70
18.28
2.4
2.1
g/l
1.3
1.6
1.74
56
161
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
143
679
2.51
18.14
2.4
2.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
152
746
2.45
17.92
1.6
1.5
g/l
3.3
2.5
3.71
127
450
(3018095) Leukocytes [#/volume] in Urine
249
1509
2.22
17.86
4.9
3.8
e6/l
25.1
126.1
2.60
206
1081
(3021879) Hepatitis B virus core Ab [Presence] in Serum
73
244
3.31
17.77
1.3
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
117
510
2.66
17.67
2.4
1.7
%
1.6
1.5
0.50
94
445
(3001122) Ferritin [Mass/volume] in Serum or Plasma
263
1661
2.16
16.66
5.4
2.6
ug/l
209.8
142.9
1.78
247
1522
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
43
106
4.33
16.20
1.3
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
109
479
2.61
16.08
9.7
8.6
kpa
12.0
12.3
0.15
104
461
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
62
209
3.23
14.82
7.3
5.3
mmol/l
23.5
24.0
0.44
57
190
(3025941) Bacteria identified in Stool by Culture
63
215
3.19
14.76
1.4
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
68
243
3.06
14.74
1.4
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
23
35
6.82
14.58
1.5
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
35
80
4.61
14.48
1.6
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
84
343
2.72
14.25
2.0
2.8
g/l
64.9
66.6
1.02
72
318
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
138
711
2.27
14.17
3.4
3.1
e6/l
2.8
1.9
0.64
84
399
(3034426) Prothrombin time (PT)
16
16
10.28
14.08
1.1
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
371
2770
2.13
14.06
9.3
3.1
u/l
131.8
50.1
12.74
356
2571
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
143
752
2.23
13.95
3.0
2.9
e6/l
1.8
1.1
0.63
87
436
(3024354) Oxygen [Partial pressure] in Venous blood
84
349
2.67
13.76
6.0
3.9
kpa
4.4
4.5
0.17
78
339
(3003396) Base excess in Arterial blood by calculation
103
475
2.45
13.58
10.1
8.7
mmol/l
0.4
1.1
0.86
84
377
(3031040) Bacteria [#/volume] in Urine by Automated count
365
2731
2.08
13.44
5.9
4.2
e6/l
52.4
2220.3
—
5
49
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
30
66
4.76
12.98
7.1
4.3
u/ml
439.6
3314.4
—
5
8
(3015377) Calcium [Moles/volume] in Serum or Plasma
222
1412
1.98
12.86
5.6
3.4
mmol/l
2.3
2.3
0.94
202
1239
(4035726)
89
395
2.51
12.69
1.7
1.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
15
16
9.62
12.60
3.7
2.8
umol/l
25.7
30.6
0.42
15
16
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
146
804
2.13
12.52
4.4
3.8
ng/l
470.2
451.2
0.02
109
640
(3026008) Bacteria identified in Urine by Culture
193
1178
2.00
12.50
3.6
3.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
27
57
4.94
12.26
1.6
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
270
1859
1.92
12.17
22.3
9.4
e9/l
0.2
0.0
0.56
221
1517
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
26
54
5.01
12.02
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
28
63
4.64
11.80
1.1
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
372
2868
1.99
11.74
5.7
4.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
102
499
2.29
11.66
1.7
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
13
13
10.23
11.38
3.0
4.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
27
61
4.61
11.32
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
32
84
3.99
11.09
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
32
84
3.99
11.09
1.4
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
169
1029
1.94
10.73
14.6
7.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
98
489
2.23
10.63
2.3
2.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
96
477
2.24
10.51
1.4
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
30
79
3.96
10.35
1.4
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
76
345
2.40
10.25
6.3
4.2
%
0.9
0.7
0.40
37
116
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
96
484
2.20
10.12
2.2
1.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
69
306
2.44
9.78
6.3
4.1
%
0.8
0.4
1.15
26
82
(3004588) Protein electrophoresis panel - Serum or Plasma
66
288
2.48
9.68
1.8
2.4
—
—
—
0
0
(3009343) pH of Capillary blood
67
295
2.45
9.64
8.2
3.9
ph
7.4
7.4
—
6
29
(21494434) Karyotype in Bone marrow
20
40
5.16
9.64
1.4
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
64
276
2.50
9.63
1.9
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
29
79
3.83
9.56
2.1
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
241
1689
1.78
9.51
5.0
3.7
ng/l
30.7
47.1
0.94
189
1215
(3021440) Promyelocytes/100 leukocytes in Blood
71
323
2.38
9.51
6.0
4.3
%
0.1
0.1
0.40
35
106
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
18
33
5.61
9.51
1.2
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
98
512
2.12
9.41
1.7
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
29
80
3.78
9.39
1.6
1.4
u/ml
329.4
269.3
0.39
19
43
(3019309) Folate [Moles/volume] in Red Blood Cells
134
786
1.94
9.33
2.1
1.7
nmol/l
1095.5
1189.2
0.55
101
597
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
34
5.44
9.22
2.3
2.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
20
42
4.91
9.13
1.4
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
29
82
3.68
9.07
1.6
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
78
379
2.24
8.96
2.6
2.1
nmol/l
371.6
372.5
0.01
69
346
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
63
279
2.43
8.94
8.6
4.0
mmol/l
1.5
1.7
0.19
49
203
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
16
28
5.86
8.85
1.1
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
93
488
2.10
8.80
2.3
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
87
446
2.14
8.74
4.9
3.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
34
110
3.23
8.68
1.2
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
237
1707
1.70
8.11
2.4
2.0
pmol/l
86.1
95.3
2.55
139
915
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
27
5.69
8.06
1.2
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
225
1604
1.70
7.96
3.4
2.3
nmol/l
74.3
77.6
1.08
206
1426
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
151
2.78
7.83
1.8
2.1
g/l
3.1
3.2
0.11
29
119
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
129
788
1.84
7.79
6.1
2.9
mmol/l
2.5
2.4
2.21
113
696
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35
124
2.95
7.69
1.7
2.2
g/l
0.0
0.0
0.50
30
117
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
37
136
2.85
7.61
1.7
2.2
g/l
1.0
1.2
0.12
31
125
(3052851) Hemolysis interference index of Serum or Plasma
35
125
2.93
7.58
5.5
3.0
—
—
—
0
0
(3024471) HLA-A [Type]
11
15
7.47
7.58
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
11
15
7.47
7.58
1.2
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
160
2.69
7.54
1.8
2.0
g/l
6.5
7.5
2.54
29
124
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
160
2.69
7.54
1.8
2.0
g/l
3.7
3.8
0.15
29
117
(3025159) Blasts/100 leukocytes in Blood
63
302
2.23
7.45
6.4
4.4
%
0.0
0.1
0.25
29
87
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
52
230
2.40
7.40
15.3
11.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
144
2.77
7.39
1.8
2.0
g/l
11.2
10.7
0.20
30
127
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
66
325
2.18
7.31
6.6
4.4
mmol/l
1.2
1.2
0.08
61
291
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
160
2.62
7.02
1.8
2.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
27
5.30
7.00
1.2
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
370
3067
1.68
6.88
5.2
3.9
mm/h
16.6
12.4
4.09
345
2813
(3052592) Norovirus Ag [Presence] in Stool
10
6
16.95
6.76
1.4
1.5
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
19
49
3.98
6.76
2.7
3.0
nmol/l
4.7
115.2
0.50
19
49
(3042111) Morphology [Interpretation] in Bone marrow Narrative
26
85
3.16
6.55
1.3
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
19
52
3.75
6.25
5.5
4.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
33
128
2.68
6.17
1.8
2.0
g/l
35.9
37.6
0.67
27
112
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
30
111
2.80
6.12
1.8
2.1
g/l
0.0
0.0
0.00
25
105
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
8
12.71
6.10
1.5
3.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
38
161
2.47
5.95
3.6
4.9
g/l
0.3
0.3
0.01
23
74
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
30
113
2.75
5.93
1.8
2.1
g/l
0.0
0.0
0.00
25
106
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
9
6
15.22
5.92
1.1
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
31
119
2.70
5.91
1.6
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
24
80
3.09
5.87
1.4
1.3
mmol/l
56.0
66.8
0.83
17
68
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
9
11.29
5.81
2.9
5.8
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
13
28
4.73
5.76
2.1
2.9
e6/l
328.2
644.2
—
6
11
(3048929) Epstein Barr virus Ab [Presence] in Serum
30
115
2.71
5.74
1.6
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
218
1638
1.56
5.73
2.6
2.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
25
87
2.97
5.70
3.3
3.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
125
822
1.68
5.68
1.3
1.2
u/ml
1.1
1.6
0.74
29
210
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
27
100
2.79
5.51
1.6
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
15
38
4.03
5.47
1.5
1.3
e6/l
5243.8
31576.4
—
8
23
(40760892) CBC W Ordered Manual Differential panel - Blood
131
882
1.64
5.41
7.5
4.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
62
335
1.96
5.36
3.0
3.1
ng/l
221.0
197.0
0.16
57
295
(3026493) Urate [Moles/volume] in Serum or Plasma
160
1134
1.59
5.35
3.9
2.7
umol/l
3154.1
8612.2
1.01
139
992
(3023199) Leukocytes [#/volume] in Pleural fluid
15
39
3.93
5.29
1.5
1.3
e6/l
3451.3
1988.6
—
8
27
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
27
103
2.71
5.23
2.3
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
16
45
3.63
5.08
1.7
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
57
305
1.97
5.07
5.8
4.0
ng/l
91.9
80.3
0.38
51
274
(3012501) Base excess in Blood by calculation
26
99
2.71
5.06
4.8
4.3
mmol/l
2.7
2.3
0.40
16
64
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
27
105
2.66
5.05
1.9
1.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
46
231
2.09
4.87
10.7
4.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
174
1281
1.53
4.84
2.9
2.0
u/l
225.1
257.6
0.17
169
1212
(3048689) Calprotectin [Mass/mass] in Stool
75
446
1.79
4.83
3.0
2.3
ug/g
259.2
141.1
1.49
68
361
(3037756) Immunofixation for Serum or Plasma
26
102
2.63
4.79
1.7
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
51
268
2.00
4.78
7.5
4.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
36
165
2.27
4.77
2.5
1.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
33
146
2.34
4.74
2.3
1.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
24
91
2.71
4.72
1.9
2.1
%
14.8
16.2
—
10
42
(3045788) Cell count panel - Pleural fluid
13
34
3.89
4.56
1.8
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
28
117
2.47
4.55
3.8
2.2
mmol/l
24.7
24.9
0.05
23
103
(40768806) Pleura Pathology biopsy report
14
39
3.66
4.51
1.6
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
27
113
2.46
4.38
2.0
4.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
25
101
2.55
4.36
2.5
1.9
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
28
120
2.41
4.32
11.7
6.4
mmol/l
2.1
1.4
0.86
22
103
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
9
9.00
4.29
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
6
11.80
4.28
1.1
1.3
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
7
6
11.80
4.28
1.3
1.2
%
100.3
103.7
—
7
6
(3009261) Glucose [Presence] in Urine by Test strip
253
2047
1.45
4.28
4.3
3.5
estimate
0.0
0.0
0.50
66
346
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
36
173
2.16
4.28
4.3
3.0
u/ml
131.1
63.6
0.46
36
167
(3035350) Ketones [Presence] in Urine by Test strip
250
2024
1.44
4.18
4.3
3.4
estimate
0.0
0.0
0.00
66
358
(3034860) Kappa light chains.free [Mass/volume] in Serum
33
155
2.20
4.15
2.0
3.6
mg/l
53.7
96.1
0.50
28
125
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
33
155
2.20
4.15
2.0
3.6
mg/l
31.6
32.7
0.08
28
126
(3048879) Bone marrow aspiration report
9
14
6.52
4.00
1.6
2.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
140
1021
1.50
3.97
2.0
1.5
nmol/l
21.3
20.4
0.24
131
863
(3019225) pH of Specimen
66
403
1.73
3.89
7.4
4.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
29
3.85
3.82
4.1
2.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
61
368
1.74
3.75
2.5
2.4
ug/l
4.0
7.4
2.54
49
325
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
25
4.06
3.71
1.2
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
25
4.06
3.71
1.2
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
30
3.72
3.65
4.3
1.6
g/l
0.9
1.0
0.68
11
30
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
166
1275
1.44
3.57
2.9
3.1
ng/l
1832.6
1430.4
0.40
132
1080
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
7
9
7.86
3.57
2.3
4.1
ug/l
3.1
1.4
—
7
9
(3021601) Nitrite [Presence] in Urine by Test strip
246
2027
1.40
3.54
5.8
4.8
estimate
0.0
0.0
0.00
66
359
(36660697) Celiac disease serology panel - Serum
50
290
1.80
3.52
1.2
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
17
63
2.75
3.52
3.2
2.8
mmol/l
104.9
104.8
0.05
17
63
(3041354) Potassium [Moles/volume] in Venous blood
17
63
2.75
3.52
3.2
2.8
mmol/l
4.4
4.1
0.95
17
63
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
42
3.15
3.39
2.8
3.1
—
—
—
0
0
(4198724)
7
10
7.07
3.37
2.4
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
10
7.07
3.37
1.4
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
55
334
1.72
3.32
5.2
3.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
54
2.83
3.28
2.1
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
452
4175
1.56
3.27
43.7
14.2
mg/l
35.5
25.1
7.33
433
3308
(3020682) Albumin/Creatinine [Ratio] in Urine
177
1394
1.40
3.26
3.8
4.0
mg/mmol
16.5
9.8
0.52
110
894
(3021901) Oxygen saturation in Capillary blood
19
78
2.49
3.25
2.3
2.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
78
2.49
3.25
1.9
2.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
169
1324
1.41
3.20
3.1
3.1
mg/l
895.7
208.9
0.62
109
848
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
8
15
5.40
3.20
1.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
11
6.43
3.19
2.7
3.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
31
159
2.01
3.16
2.3
3.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
16
61
2.67
3.16
2.1
1.6
pg
31.4
32.9
0.70
16
61
(3033705) Calcium.ionized [Moles/volume] in Venous blood
16
62
2.63
3.07
3.3
2.8
—
—
—
0
0
(3013512) EKG study
164
1287
1.40
3.06
5.1
4.0
—
—
—
0
0
(44806071)
5
5
10.08
2.98
1.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
5
10.08
2.98
1.2
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
119
1553
0.70
2.97
3.3
2.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
22
101
2.23
2.97
2.5
3.2
—
—
—
0
0
(3020891) Body temperature
31
163
1.96
2.96
4.0
4.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
11
35
3.19
2.94
1.5
1.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
17
4.76
2.93
1.8
1.6
ug/l
73.1
63.9
—
8
17
(3009508) Creatinine [Moles/volume] in Urine
174
1388
1.38
2.92
3.1
3.2
mmol/l
7.7
7.9
0.15
143
1156
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
76
2.42
2.92
1.7
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
22
4.14
2.89
1.1
1.2
nmol/l
168.9
137.2
—
9
22
(3019230) Fractional oxyhemoglobin in Venous blood
19
83
2.34
2.87
1.9
2.5
%
62.9
61.9
0.06
19
83
(4062490)
11
36
3.10
2.82
2.5
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
23
3.96
2.78
5.1
2.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
144
1122
1.39
2.77
4.6
3.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
42
2.90
2.76
4.2
2.8
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
6
8.40
2.75
1.4
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
6
8.40
2.75
1.0
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
6
8.40
2.75
1.4
1.2
%
86.6
92.8
—
5
6
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
54
2.64
2.72
1.6
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
112
2.10
2.71
1.2
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
6
10
6.05
2.70
1.2
1.1
%
81.5
117.1
—
6
10
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
32
3.17
2.66
1.9
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
113
2.08
2.65
1.2
1.2
—
—
—
0
0
(44790047)
13
49
2.69
2.64
3.4
1.8
—
—
—
0
0
(44790049)
13
49
2.69
2.64
3.4
1.8
—
—
—
0
0
(44806118)
13
49
2.69
2.64
3.4
1.8
—
—
—
0
0
(44790048)
13
49
2.69
2.64
3.4
1.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
55
2.59
2.63
1.6
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
55
2.59
2.63
1.6
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
55
2.59
2.63
1.6
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
14
55
2.59
2.63
3.7
2.8
mg/l
21.6
24.1
—
5
14
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
55
2.59
2.63
1.6
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
23
114
2.06
2.60
1.2
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
8
20
4.04
2.57
2.8
3.9
nmol/l
81.0
100.6
—
8
20
(3001186) Copper [Moles/volume] in Serum or Plasma
5
7
7.20
2.55
1.8
1.0
umol/l
16.1
19.5
—
5
7
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
56
2.54
2.55
1.6
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
16
70
2.33
2.43
2.8
1.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
8
6.30
2.37
1.2
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
46
2.65
2.37
1.9
2.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
17
4.16
2.36
2.6
2.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
17
4.16
2.36
2.6
2.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
18
353
0.49
2.35
1.6
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
20
98
2.08
2.34
1.6
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
9
5.60
2.22
1.2
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
67
2.27
2.19
5.2
3.7
%
64.4
58.3
0.87
15
67
(3003694) ABO and Rh group [Type] in Blood
138
1106
1.33
2.18
1.5
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
19
3.72
2.15
1.3
2.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
19
3.72
2.15
1.3
2.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
19
3.72
2.15
1.3
2.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
19
3.72
2.15
1.3
2.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
30
3.03
2.15
1.2
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
74
536
1.44
2.14
1.3
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
120
1495
0.75
2.13
3.9
4.2
%
19.6
21.2
0.58
54
685
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
43
2.59
2.11
2.0
1.9
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
11
43
2.59
2.11
2.2
2.3
ml
565.2
578.1
—
6
24
(3044927) Protein electrophoresis panel - Urine
11
43
2.59
2.11
1.2
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
25
3.23
2.10
4.3
2.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
34
207
1.69
2.10
3.0
2.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
10
5.04
2.07
2.0
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
10
5.04
2.07
2.2
1.6
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
9
32
2.84
2.01
2.3
1.0
promille
1.6
1.2
—
9
24
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
51
2.38
1.96
1.9
2.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
11
4.58
1.94
4.4
1.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
16
3.78
1.94
1.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
71
2.15
1.94
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
33
2.76
1.94
1.8
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
49
336
1.50
1.88
3.6
2.6
ml/min/173m2
71.7
65.6
0.62
21
134
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
28
2.88
1.87
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
28
168
1.70
1.84
1.4
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
35
2.60
1.81
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
8
29
2.78
1.79
2.0
2.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
86
1097
0.74
1.77
2.8
3.0
ug/l
0.6
0.7
1.72
54
703
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
18
3.36
1.75
1.2
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
24
2.94
1.72
2.7
1.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
24
2.94
1.72
2.1
2.3
u/ml
1473.1
847.0
—
7
24
(3029937) Albumin [Presence] in Urine by Test strip
133
1094
1.29
1.72
5.1
3.6
estimate
0.0
0.0
0.50
60
344
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
55
2.21
1.68
1.5
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
62
2.12
1.67
1.5
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
25
2.82
1.65
1.0
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
14
3.59
1.62
1.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
14
3.59
1.62
1.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
14
3.59
1.62
2.4
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
26
2.71
1.58
5.6
2.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
7
26
2.71
1.58
1.6
1.3
u/l
18.3
14.9
—
7
26
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
57
2.13
1.56
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
18
100
1.83
1.55
1.1
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
33
2.45
1.54
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
33
2.45
1.54
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
33
2.45
1.54
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
33
2.45
1.54
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
33
2.45
1.54
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
33
218
1.55
1.53
1.1
1.2
iu/ml
67.0
147.2
—
9
88
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
15
3.35
1.52
1.4
2.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
15
3.35
1.52
1.2
2.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
15
3.35
1.52
1.2
2.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
27
2.61
1.52
2.3
4.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
183
1586
1.23
1.50
4.9
3.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
65
2.03
1.50
4.9
3.1
e9/l
3.7
4.6
0.86
13
65
(40768795) Lymph node Pathology biopsy report
10
45
2.25
1.47
1.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
28
2.52
1.45
6.3
3.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
46
2.20
1.40
2.6
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
29
2.43
1.39
1.6
3.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
60
2.02
1.39
1.8
2.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
333
0.62
1.38
1.5
1.8
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
17
2.96
1.36
8.8
7.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
38
267
1.46
1.34
3.6
2.7
e9/l
4.4
3.9
0.23
27
208
(1761482) Bacteria [#/volume] in Urine by Culture
20
121
1.68
1.32
5.8
4.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
261
2367
1.20
1.32
3.1
2.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
459
4407
1.31
1.31
45.0
16.6
mmol/l
138.8
139.7
10.44
452
4292
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
34
2.37
1.29
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
34
2.37
1.29
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
34
2.37
1.29
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
18
2.79
1.28
1.4
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
55
2.02
1.28
2.8
4.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
36
2.24
1.24
1.3
2.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
36
2.24
1.24
1.3
2.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
36
2.24
1.24
1.3
2.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
28
188
1.52
1.24
2.0
3.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
226
0.56
1.23
1.6
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
37
2.18
1.22
1.9
3.6
%
11.6
10.8
—
8
37
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
86
1.77
1.20
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
6
26
2.32
1.19
1.7
1.8
—
—
—
0
0
(4094501)
6
128
0.46
1.18
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
20
2.51
1.15
1.0
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
65
1.87
1.14
1.6
1.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
459
4424
1.28
1.14
45.4
16.8
mmol/l
4.0
4.0
1.73
452
4304
(3015171) Extractable nuclear Ab [Units/volume] in Serum
20
127
1.60
1.13
1.4
1.2
—
2.1
—
0
9
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
51
1.98
1.12
1.7
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
109
922
1.23
1.11
3.3
3.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
66
1.84
1.09
1.5
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
13
74
1.78
1.07
1.2
1.3
—
—
—
0
0
(3000492) Spirometry study
51
395
1.32
1.06
1.6
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
100
1174
0.82
1.04
1.8
1.7
mmol/l
1.6
1.4
0.88
83
982
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
46
1.97
1.04
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
22
2.28
1.03
3.4
2.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
400
4171
0.83
1.01
5.1
4.5
mmol/l
1.3
1.4
4.13
363
3827
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
115
1.59
1.00
1.7
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
61
1.82
0.99
1.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
61
1.82
0.99
1.0
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
324
3041
1.17
0.98
4.5
3.9
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
29
0.00
0.98
0.0
1.0
—
228.6
—
0
14
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
29
0.00
0.98
0.0
1.0
—
32.5
—
0
13
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
29
0.00
0.98
0.0
1.0
—
576.4
—
0
15
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
36
1.96
0.97
1.4
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
36
1.96
0.97
1.0
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
125
1.54
0.95
1.8
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
28
2.16
0.91
1.7
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
102
1.59
0.91
1.3
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
29
2.08
0.89
1.8
1.1
u/l
126.5
700.1
—
6
24
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
6
29
2.08
0.89
1.3
2.6
—
42.6
—
0
9
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
168
1860
0.86
0.89
4.3
4.8
ug/l
2.4
2.3
0.07
143
1671
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
30
2.01
0.87
1.3
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
399
3827
1.17
0.84
42.3
15.5
%
37.3
39.9
5.28
281
2710
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
405
4198
0.85
0.83
5.2
4.6
mmol/l
4.4
4.6
2.72
370
3869
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
33
1.83
0.79
3.2
2.9
u/ml
35.5
49.7
—
6
33
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
25
0.00
0.79
0.0
1.0
—
1.1
—
0
14
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
415
4000
1.17
0.79
35.1
13.1
ml/min/173m2
81.2
79.3
1.00
371
3283
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
25
184
1.38
0.75
1.8
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
167
1.39
0.75
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
69
583
1.21
0.74
1.6
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
135
0.59
0.74
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
38
1.85
0.73
1.0
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
62
519
1.22
0.73
10.7
6.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.4
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.4
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
16
109
1.48
0.71
2.2
1.6
e6/l
13632.0
13323.1
—
8
79
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
26
1.93
0.71
1.2
1.4
ug/l
3.9
6.5
—
5
21
(3024263) Appearance of Synovial fluid
5
26
1.93
0.71
1.8
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
41
1.72
0.70
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
58
1.56
0.70
1.9
1.3
—
—
—
0
0
(1002224) Polysomnography panel
11
168
0.65
0.68
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
34
422
0.79
0.62
1.6
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(4027681)
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
102
912
1.15
0.58
1.7
1.7
pmol/l
524.1
20584764.9
0.69
79
753
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
81
1.49
0.57
2.9
3.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
38
1.59
0.54
1.3
1.9
—
—
—
0
0
(4010399)
38
314
1.23
0.53
1.8
1.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
62
1.46
0.53
1.7
1.6
ug/l
20.5
18.0
—
9
62
(3021788) Differential panel - Synovial fluid
11
75
1.48
0.51
1.9
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
65
1.39
0.51
3.7
2.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
13
93
1.41
0.48
1.8
2.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
47
1.50
0.47
15.4
4.6
mmol/l
9.6
6.9
—
7
39
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
406
4161
0.90
0.47
5.2
4.6
mmol/l
6.4
6.0
3.58
362
3790
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
419
4286
0.89
0.46
5.5
5.1
mmol/l
2.6
2.7
3.19
376
3934
(3004616) Nuclear Ab [Presence] in Serum
7
49
1.43
0.46
1.3
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
27
220
1.24
0.44
5.5
3.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
62
548
1.15
0.43
5.2
4.6
%
32.6
31.2
0.34
47
363
(3005322) IgE [Units/volume] in Serum or Plasma
27
221
1.23
0.43
1.2
1.3
u/ml
490.9
289.9
0.22
27
200
(3000963) Hemoglobin [Mass/volume] in Blood
461
4684
0.88
0.42
61.4
20.9
g/l
126.6
136.6
24.87
455
4606
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
59
1.36
0.41
1.3
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
394
4034
0.91
0.41
4.9
4.1
mmol/l
1.4
1.3
1.79
356
3683
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
36
306
1.19
0.41
1.2
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
447
4387
1.12
0.40
39.4
13.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
461
4682
0.88
0.40
60.9
20.8
e9/l
7.7
6.7
1.19
448
4542
(3026361) Erythrocytes [#/volume] in Blood
461
4682
0.88
0.40
60.9
20.8
e12/l
4.3
4.5
11.92
446
4543
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
461
4681
0.88
0.39
60.5
20.7
pg
30.1
30.4
2.67
456
4606
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
458
4503
1.12
0.39
28.8
10.3
u/l
35.0
27.1
8.33
449
4346
(3024731) MCV [Entitic volume]
461
4680
0.89
0.39
60.7
20.7
fl
91.0
91.2
0.36
456
4605
(3007461) Platelets [#/volume] in Blood
461
4680
0.89
0.39
60.8
20.8
e9/l
235.9
245.8
1.13
450
4551
(3045424) Erythrocytes [Presence] in Urine
9
66
1.37
0.38
1.3
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
67
1.35
0.38
1.4
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
16
126
1.28
0.35
3.1
2.4
ug/min
27.1
90.8
—
9
74
(21494890) Protein electrophoresis panel - 24 hour Urine
6
43
1.40
0.35
1.3
2.6
—
—
—
0
0
(4034850)
11
144
0.76
0.33
18.5
10.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
47
1.28
0.32
1.0
1.3
nmol/l
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
76
1.32
0.28
1.8
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
126
0.79
0.24
2.6
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
10
79
1.27
0.22
1.3
1.9
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.2
—
17.4
—
0
11
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
402
3965
1.06
0.20
7.6
5.9
mmol/mol
44.1
40.2
4.28
371
3679
(3019150) Specific gravity of Urine by Refractometry
94
892
1.07
0.19
4.6
3.6
kg/l
1.0
1.0
0.06
16
136
(3005570) Glucose [Moles/volume] in Urine
6
51
1.18
0.19
1.0
2.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
26
290
0.89
0.18
2.1
2.5
—
12.1
—
0
10
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
312
3062
1.05
0.18
4.1
3.6
pmol/l
14.9
14.9
0.08
279
2745
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
101
1.19
0.16
1.2
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
244
1.11
0.16
1.2
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
92
1.20
0.16
2.5
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
38
351
1.09
0.16
3.9
3.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
72
1.11
0.16
2.0
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
14
161
0.87
0.15
3.4
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
19
169
1.13
0.14
1.7
1.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
88
0.79
0.14
2.1
2.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
25
227
1.11
0.14
1.9
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
96
0.83
0.14
1.1
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
94
1.17
0.13
2.5
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
15
168
0.89
0.12
1.3
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
12
105
1.15
0.11
1.8
1.9
pmol/l
152.7
236.4
2.85
12
97
(3027944) Amphetamines [Presence] in Urine
11
97
1.14
0.09
2.5
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
97
1.14
0.09
2.5
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
113
0.88
0.08
1.1
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
67
1.05
0.08
1.1
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
112
0.89
0.07
1.1
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
78
1.03
0.07
2.0
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
82
0.85
0.07
1.7
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
376
3782
0.98
0.06
4.9
4.3
mu/l
2.1
2.3
0.19
338
3413
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
27
257
1.05
0.05
2.1
1.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
67
656
1.02
0.04
1.3
1.3
iu/ml
27.4
39.4
0.46
17
203
(3017446) Testosterone [Moles/volume] in Serum or Plasma
40
388
1.03
0.04
2.1
2.2
nmol/l
11.6
14.0
1.11
35
349
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
25
259
0.96
0.02
1.1
1.3
—
43.6
—
0
17
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
64
630
1.02
0.02
1.3
1.3
u/ml
11.8
12.8
0.04
17
245
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
127
0.94
0.01
1.5
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
42
414
1.02
0.00
1.3
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
97
1.03
0.00
2.6
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
27
269
1.00
0.00
3.6
2.8
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
18.3
—
0
9
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
6.5
—
0
6
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
18.1
—
0
5
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
1.8
—
0
8
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
40.0
—
0
6
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
55
0.91
0.00
1.0
1.3
nmol/l
1.0
0.6
—
5
50
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
0
6
0.00
0.00
0.0
8.3
—
36.0
—
0
6
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
6
64
0.94
0.00
1.2
1.1
—
13.2
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4015189)
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_PVT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_PVT | 2.849 [2.24, 3.63] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.487 |
During the follow-up period (1.1.1998 — 31.12.2019), 395 out of 988 females with I9_PVT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_PVT | 4.077 [3.25, 5.12] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.021 |
During the follow-up period (1.1.1998 — 31.12.2019), 649 out of 1429 males with I9_PVT died.
Mortality risk
Mortality risk for people of age
years, who have I9_PVT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.295% | 0.843% |
| 5 | 1.882% | 4.944% |
| 10 | 4.634% | 12.337% |
| 15 | 8.574% | 21.809% |
| 20 | 14.689% | 34.055% |
Relationships between endpoints
↥Index endpoint: I9_PVT – Portal vein thrombosis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data